Diabetes warning coming for schizophrenia drugs
The U.S. Food and Drug Administration will require labels on several drugs used to treat schizophrenia to include new warnings about the associated risk of developing diabetes. Psychiatric News writer Jim Rosack details the controversy behind the new warnings in this article.
Posted by Carla :: 05:47 PM Oct 21
